VEKTIS
The composite efficacy score increased significantly over the treatment period. The difference in the least-squares (LS) mean for both the CsA CE 0.1% QID (0.76; 95% CI: 0.26, 1.27) and BID group (0.67; 95% CI: 0.16, −1.18) was significant compared with vehicle (